Related Experiment Video

Updated: Jun 20, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K

Systemic therapy landscape of advanced prostate cancer

Asit K Paul1, John W Melson1, Samina Hirani2

  • 1Department of Internal Medicine, Division of Hematology, Oncology and Palliative Care, Virginia Commonwealth University, Richmond, VA, United States; VCU Massey Comprehensive Cancer Center, Richmond, VA, United States.

Advances in Cancer Research
|July 20, 2024
PubMed

Insights

Advanced prostate cancer treatment is evolving with new drugs and strategies. Androgen deprivation therapy (ADT) remains key, but novel agents and combination approaches are improving patient outcomes.

Area of Science:

  • Oncology
  • Urology

Background:

  • Prostate cancer is a leading cause of cancer death in American men.
  • Androgen deprivation therapy (ADT) is the standard treatment for advanced prostate cancer.

Purpose of the Study:

  • To review the evolving treatment landscape for advanced prostate cancer.
  • To highlight new therapeutic agents and strategies.

Main Methods:

  • Review of recent clinical trials and therapeutic advancements.
  • Focus on novel androgen receptor pathway inhibitors, targeted agents, and radionuclide therapies.
  • Discussion of new treatment strategies including ADT intensification, combination therapies, and treatment sequencing.

Main Results:

  • New therapeutics have shown improved clinical outcomes in randomized trials.
  • Emerging strategies like early ADT intensification and novel combinations offer further potential.

Conclusions:

  • The treatment of advanced prostate cancer is rapidly advancing.
  • New therapeutics and strategies are enhancing patient outcomes and survival.
Keywords:
AR-pathway inhibitorAndrogen deprivation therapyAntiandrogenChemotherapyPARP-inhibitorProstate cancerSystemic therapy

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K